These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12054112)

  • 1. A case of growth failure caused by 13-CIS-retinoic acid administration after bone marrow transplantation for neuroblasoma.
    Inamo Y; Suzuki T; Mugishima H
    Endocr J; 1999 Mar; 46 Suppl():S113-5. PubMed ID: 12054112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
    Villablanca JG; Khan AA; Avramis VI; Seeger RC; Matthay KK; Ramsay NK; Reynolds CP
    J Clin Oncol; 1995 Apr; 13(4):894-901. PubMed ID: 7707116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of advanced bone age in a cohort of patients who received cis-retinoic acid for high-risk neuroblastoma.
    Hobbie WL; Mostoufi SM; Carlson CA; Gruccio D; Ginsberg JP
    Pediatr Blood Cancer; 2011 Mar; 56(3):474-6. PubMed ID: 21072832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 13-cis-retinoic acid-induced eosinophilia following autologous bone marrow transplantation for neuroblastoma.
    Degar BA; Harrington RD; Rappeport JM; Woolfrey AE
    Med Pediatr Oncol; 1999 Apr; 32(4):308-10. PubMed ID: 10102029
    [No Abstract]   [Full Text] [Related]  

  • 5. Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma.
    Steineck A; MacKenzie JD; Twist CJ
    Pediatr Blood Cancer; 2016 Nov; 63(11):2050-3. PubMed ID: 27399265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth Failure Caused by Premature Epiphyseal Closure in a Child Treated with Isotretinoin for Neuroblastoma.
    Hoemberg S; Reinhard H
    Klin Padiatr; 2017 May; 229(3):175-176. PubMed ID: 28561229
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.
    Khan AA; Villablanca JG; Reynolds CP; Avramis VI
    Cancer Chemother Pharmacol; 1996; 39(1-2):34-41. PubMed ID: 8995497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized metaphyseal modification with cone-shaped epiphyses following long-term administration of 13-cis-retinoic acid.
    Nishimura G; Mugishima H; Hirao J; Yamato M
    Eur J Pediatr; 1997 Jun; 156(6):432-5. PubMed ID: 9208235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of high-risk neuroblastoma with intensive chemotherapy, autologous peripheral blood stem cell transplantation, and 13-cis-retinoic acid].
    Tang SQ; Huang DS; Wang JW; Zhang XF; Liu LZ; Yu F; Yang G
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):486-9. PubMed ID: 15324562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genu varum deformity due to premature epiphyseal closure after treatment with isotretinoin for neuroblastoma: A case report.
    Park WK; Choi HS; Chung CY; Park MS; Sung KH
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020924483. PubMed ID: 32425129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature Epiphyseal Closure of the Lower Extremities Contributing to Short Stature after cis-Retinoic Acid Therapy in Medulloblastoma: A Case Report.
    Noyes JJ; Levine MA; Belasco JB; Mostoufi-Moab S
    Horm Res Paediatr; 2016; 85(1):69-73. PubMed ID: 26457578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma.
    Marabelle A; Sapin V; Rousseau R; Periquet B; Demeocq F; Kanold J
    Pediatr Blood Cancer; 2009 Feb; 52(2):280-3. PubMed ID: 18839433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma.
    Belden TL; Ragucci DP
    Pharmacotherapy; 2002 May; 22(5):645-8. PubMed ID: 12013365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
    Park JR; Villablanca JG; London WB; Gerbing RB; Haas-Kogan D; Adkins ES; Attiyeh EF; Maris JM; Seeger RC; Reynolds CP; Matthay KK;
    Pediatr Blood Cancer; 2009 Jan; 52(1):44-50. PubMed ID: 18937318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid.
    Villablanca JG; Khan AA; Avramis VI; Reynolds CP
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):410-5. PubMed ID: 8214363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 13-cis-retinoic acid-associated bone marrow edema in neuroblastoma.
    Sato Y; Kuwashima S; Kurosawa H; Sugita K; Fukushima K; Arisaka O
    Pediatr Blood Cancer; 2012 Sep; 59(3):589-90. PubMed ID: 22354520
    [No Abstract]   [Full Text] [Related]  

  • 17. Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature.
    Duvalyan A; Cha A; Goodarzian F; Arkader A; Villablanca JG; Marachelian A
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28236. PubMed ID: 32386124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma.
    Cross SF; Dalla Pozza L; Munns CF
    Pediatr Blood Cancer; 2009 Oct; 53(4):666-8. PubMed ID: 19492317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
    Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
    Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.
    Finklestein JZ; Krailo MD; Lenarsky C; Ladisch S; Blair GK; Reynolds CP; Sitarz AL; Hammond GD
    Med Pediatr Oncol; 1992; 20(4):307-11. PubMed ID: 1608352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.